Insulin resistance in T2DM leads to hyperinsulinemia, potentially promoting tumor growth directly by acting on insulin receptors or indirectly by increasing levels of insulin-like growth factor-1 (IGF-1), both of which can stimulate cell proliferation and inhibit apoptosis to enhance cell proliferation pathways [36,37,38]. The gene discussed is IGF1; the disease is Insulin resistance.